Larimar Therapeutics
LRMR
LRMR
68 hedge funds and large institutions have $174M invested in Larimar Therapeutics in 2023 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 23 increasing their positions, 12 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0.78% less ownership
Funds ownership: 89.59% → 88.82% (-0.78%)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $3K
Holders
68
Holding in Top 10
2
Calls
–
Puts
$3K
Top Buyers
| 1 | +$2.84M | |
| 2 | +$2.1M | |
| 3 | +$1.29M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$1.16M |
| 5 |
Millennium Management
New York
|
+$1M |
Top Sellers
| 1 | -$3.29M | |
| 2 | -$3.1M | |
| 3 | -$2.62M | |
| 4 |
MP
Mangrove Partners
Greenwich,
Connecticut
|
-$2.21M |
| 5 |
Morgan Stanley
New York
|
-$2.16M |